Your browser doesn't support javascript.
loading
Adjuvant lymph-node field radiotherapy versus observation only in patients with melanoma at high risk of further lymph-node field relapse after lymphadenectomy (ANZMTG 01.02/TROG 02.01): 6-year follow-up of a phase 3, randomised controlled trial.
Henderson, Michael A; Burmeister, Bryan H; Ainslie, Jill; Fisher, Richard; Di Iulio, Juliana; Smithers, B Mark; Hong, Angela; Shannon, Kerwin; Scolyer, Richard A; Carruthers, Scott; Coventry, Brendon J; Babington, Scott; Duprat, Joao; Hoekstra, Harald J; Thompson, John F.
Affiliation
  • Henderson MA; Division of Cancer Surgery, University of Melbourne Department of Surgery, East Melbourne, VIC, Australia; University of Melbourne, East Melbourne, VIC, Australia. Electronic address: michael.henderson@petermac.org.
  • Burmeister BH; Princess Alexandra Hospital, University of Queensland, Brisbane, QLD, Australia.
  • Ainslie J; Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia.
  • Fisher R; Centre for Biostatistics and Clinical Trials, East Melbourne, VIC, Australia.
  • Di Iulio J; Centre for Biostatistics and Clinical Trials, East Melbourne, VIC, Australia.
  • Smithers BM; Princess Alexandra Hospital, University of Queensland, Brisbane, QLD, Australia.
  • Hong A; Melanoma Institute of Australia, University of Sydney, Sydney, NSW, Australia.
  • Shannon K; Melanoma Institute of Australia, University of Sydney, Sydney, NSW, Australia.
  • Scolyer RA; Melanoma Institute of Australia, University of Sydney, Sydney, NSW, Australia.
  • Carruthers S; Royal Adelaide Hospital, University of Adelaide, Adelaide, SA, Australia.
  • Coventry BJ; Royal Adelaide Hospital, University of Adelaide, Adelaide, SA, Australia.
  • Babington S; Christchurch Hospital, Christchurch, New Zealand.
  • Duprat J; Hospital Do Cancer, Sao Paulo, Brazil.
  • Hoekstra HJ; University Medical Centre Groningen, Groningen, Netherlands.
  • Thompson JF; Melanoma Institute of Australia, University of Sydney, Sydney, NSW, Australia.
Lancet Oncol ; 16(9): 1049-1060, 2015 Sep.
Article in En | MEDLINE | ID: mdl-26206146
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Radiotherapy, Adjuvant / Lymph Nodes / Melanoma Type of study: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Aspects: Patient_preference Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Lancet Oncol Journal subject: NEOPLASIAS Year: 2015 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Radiotherapy, Adjuvant / Lymph Nodes / Melanoma Type of study: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Aspects: Patient_preference Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Lancet Oncol Journal subject: NEOPLASIAS Year: 2015 Document type: Article